These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25033481)

  • 21. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 22. At last, a RE-LYable alternative to warfarin for atrial fibrillation.
    Hankey GJ
    Int J Stroke; 2009 Dec; 4(6):454-5. PubMed ID: 19930055
    [No Abstract]   [Full Text] [Related]  

  • 23. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 24. Ask the doctor. I am 95 years old and recently began treatment for early macular degeneration in one eye. My retinologist said that PreserVision might help protect the other eye. But she cautioned that it contains a large dose of vitamin E, which could cause a bleeding problem with the Coumadin I take because of a mechanical aortic valve. What would you suggest?
    Goldhaber SZ
    Harv Heart Lett; 2010 Apr; 20(8):7. PubMed ID: 20590010
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulation for atrial fibrillation.
    Greiver M
    Can Fam Physician; 2005 Dec; 51(12):1629. PubMed ID: 16805080
    [No Abstract]   [Full Text] [Related]  

  • 26. Ask the doctor. I am due to have a colonoscopy. My cardiologist told me that I will need to stop taking Coumadin, which I take for atrial fibrillation, a few days before the procedure and get some injections. Is this really necessary?
    Goldhaber SZ
    Harv Heart Lett; 2009 Jun; 19(10):8. PubMed ID: 19681210
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis.
    Ghate SR; Biskupiak JE; Ye X; Hagan M; Kwong WJ; Fox ES; Brixner DI
    Ann Pharmacother; 2011 Jun; 45(6):701-12. PubMed ID: 21666081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
    Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C
    Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
    Lang NN; Connelly DT
    J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bleeding problems of a patient with hypothyroidism].
    Paul R
    Duodecim; 2002; 118(13):1361-3. PubMed ID: 12239881
    [No Abstract]   [Full Text] [Related]  

  • 31. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the risk of bleeding in patients taking warfarin.
    Ebell MH
    Am Fam Physician; 2010 Mar; 81(6):780. PubMed ID: 20229978
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistence with therapy among patients treated with warfarin for atrial fibrillation.
    Gomes T; Mamdani MM; Holbrook AM; Paterson JM; Juurlink DN
    Arch Intern Med; 2012 Nov; 172(21):1687-9. PubMed ID: 23090098
    [No Abstract]   [Full Text] [Related]  

  • 36. Atrial fibrillation: stroke prevention in older adults.
    Quinn GR; Fang MC
    Clin Geriatr Med; 2012 Nov; 28(4):617-34. PubMed ID: 23101573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
    Cheng HY
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
    [No Abstract]   [Full Text] [Related]  

  • 39. Prompt recognition and treatment in traumatic retro-orbital hematoma in anticoagulated elderly people can save sight.
    Scott M; Thomson A
    J Am Geriatr Soc; 2009 Mar; 57(3):568-9. PubMed ID: 19278406
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.